longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

ALK

002940

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

About

ALK
ALK
002940.SZ

Zhejiang AngLiKang Pharmaceutical CO.,LTD. engages in the research, development, production, and sale of pharmaceuticals in China and internationally. The company offers chemical raw materials for pharmaceuticals comprising oral cephalosporin antibiotic raw materials, including cephalexin, cefadroxil, cefaclor, and cefadroxil; alpha-keto acid raw materials; inhaled anesthetic raw materials, such as isoflurane and sevoflurane; and anti-androgen intermediates, including finasteride and dutasteride. It also provides chemical agents consisting of anti-infective preparations, such as cefixime and cefadroxil capsules, cefaclor sustained-release tablets, cefaclor granules, and cefalexin capsules; cardiovascular preparations, including levamlodipine besylate and amlodipine besylate tablets, nifedipine sustained-release and sacubitril/valsartan sodium tablets, and measartan potassium and ticagrelor tablets; anesthetic and analgesic preparations, such as sevoflurane inhalation, liprocaine cream, and pregabalin capsules; nephropathy preparations, including compound a-keto acid tablets, levocarnitine oral solutions, and lanthanum carbonate chewable tablets; oryzanol and doxofylline tablets; and other products.

Profile

Company Name
Zhejiang AngLiKang Pharmaceutical CO.,LTD.
Market
SZSE
Founded
2001-12-30
Industry
--
Fiscal Year End
December 31
Website
www.alkpharm.com